Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series

Clin Microbiol Infect. 2023 Mar;29(3):393-395. doi: 10.1016/j.cmi.2022.11.005. Epub 2022 Nov 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cefiderocol
  • Cephalosporins* / pharmacology
  • Drug Resistance, Multiple, Bacterial
  • Gram-Negative Bacteria
  • Gram-Negative Bacterial Infections* / drug therapy
  • Humans
  • Microbial Sensitivity Tests

Substances

  • Cephalosporins
  • Anti-Bacterial Agents